Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NJ Endovascular & Amputation Prevention is a New Jersey vascular and interventional radiology practice focused on minimally invasive, image-guided procedures delivered in a commercial care setting. The group emphasizes limb salvage and amputation prevention by restoring blood flow in patients with peripheral artery disease and other severe vascular disorders. Its service offering also includes treatment for venous disease, deep vein thrombosis, uterine fibroids through embolization, aneurysm repair, and wound-healing support. The organization appears to operate as a physician-led healthcare services business rather than a drug-development biotech or pharmaceutical company. Its business model is centered on outpatient and hospital-based procedural care rather than a therapeutic product pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NJ Endovascular & Amputation Prevention.